Human immunodeficiency Virus (HIV)

all Activators (8) Antagonists (4) Inducer (1) Inhibitors (721)

CAS No.	Product Name	Inquiry
1133378-37-6	Darunavir-[d9] Darunavir-[d9] is a labelled Darunavir. Darunavir is an antiretroviral medication for the prevention of HIV/AIDS.
1133702-41-6	Fosamprenavir-d4 Fosamprenavir-d4 is deuterium labeled Fosamprenavir. Fosamprenavir (Amprenavir phosphate;GW 433908) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility. Anti-HIV infection.
113852-41-8	PMEDAP PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication with anti-murine cytomegalovirus (MCMV) activity, and is a very potent inhibitor of moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality. It has been studied for potential treatment of feline herpesvirus 1 (FHV-1).
1141453-73-7	Kuguacin N
1142096-06-7	Etravirine-[d6] Etravirine-[d6] is the labelled analogue of Etravirine. Etravirine is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor.
1149348-10-6	FGI-106-tetrahydrochloride FGI-106 tetrahydrochloride is a potent and broad-spectrum inhibitor with inhibitory activity against multiple viruses. FGI- 106 tetrahydrochloride is active against Ebola, Rift Valley and Dengue Fever viruses with EC50s of 100 nM, 800 nM and 400-900 nM, respectively. FGI-106 tetrahydrochloride also inhibits non-hemorrhagic fever viruses HCV and HIV-1 with EC50s of 200 nM and 150 nM, respectively.
114987-18-7	Adenallene
115416-08-5	HIV gp120 (308-331)
1155419-89-8	BI 224436 BI 224436 is a novel HIV-1 non-catalytic-site integrase inhibitor; has antiviral EC50s of <15 nM against different HIV-1 laboratory strains and cellular cytotoxicity of >90 μM.
1159840-61-5	Gardiquimod-diTFA Gardiquimod diTFA, an imidazoquinoline analog, is a TLR7/8 agonist. Gardiquimod diTFA could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod diTFA specifically activates TLR7 when used at concentrations below 10 μM.
116249-65-1	Benanomicin A Benanomicin A is produced by the strain of Actinomadura sp. MH193-16F4. A and B have anti-candida, Cryptococcus neoforme, Saccharomyces cerevisiae and other fungal activities, while A has stronger activity. Xylose benamycin A and B showed similar or slightly stronger activity against candida, yeast and Cryptococcus, but decreased activity against aspergillus. The antifungal activity of 2-demethylbenamycin was similar to that of xylose Benamycin A. The synthesized 7-methoxybenamycin had little antifungal activity, but showed inhibitory activity of glucosinolase (EC 3.2.1.20) with IC50 of 60μg/mL.
1174719-68-6	WRNA10 WRNA10 is a potent HIV-1 TAR RNA binder with an IC50 of 10 µM and an CC50 of 40 µM.
117704-65-1	Pradimicin A Pradimicin A is an antibiotic produced by Actinomadura hibisca. It has strong antifungal and yeast activity.
1185237-51-7	Panobinostat-[d4] Panobinostat-[d4], is the labelled analogue of Panobinostat. Panobinostat is a drug for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor.
1185451-72-2	CXCR4 antagonist 7
1185878-98-1	Pentoxifylline-[d6] Pentoxifylline-[d6] is the labelled analogue of Pentoxifylline which is a competitive nonselective phosphodiesterase inhibitor.
1185995-18-9	Pentoxifylline-[d5] Pentoxifylline-[d5] is the labelled analogue of Pentoxifylline. Pentoxifylline can be used for the treatment of muscle pain in people with peripheral artery disease.
1187917-12-9	AIC-292 AIC-292 is a potent and selective inhibitor of HIV-1 nonnucleoside reverse transcriptase. It inhibits wild-type HIV-1 laboratory strains at low nanomolar concentrations. AIC-292 displays potent antiviral in vivo efficacy in a mouse xenograft model.
1189471-66-6	rac α-Lipoic Acid-[d5] rac α-Lipoic Acid-[d5] is the labelled analogue of rac α-Lipoic Acid, which is a fat-metabolism stimulator.
1189657-87-1	Probenecid-d14 Probenecid-[d14] is the labelled analogue of Probenecid. Probenecid is a drug that increases the excretion of uric acid in the urine and can be used to treat gout and hyperuricemia.

※ Please kindly note that our services are for research use only.